A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

To evaluate the effects of a single dose of trientine in children ≥6 years and adult patients with Wilson's disease.

Phase 1

Univar BV

Aptiv Solutions

Trientine